Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2023

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

Commission File Number: 001-35992

Oracle Corporation

(Exact name of registrant as specified in its charter)

Delaware

54-2185193

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

2300 Oracle Way

Austin, Texas

78741

(Address of principal executive offices)

(Zip Code)

(737) 867-1000

(Registrant s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

3.125% senior notes due July 2025

ORCL

New York Stock Exchange

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

The number of shares of registrant s common stock outstanding as of March 6, 2023 was: 2,699,802,000.

Table of Contents

ORACLE CORPORATION

FORM 10-Q QUARTERLY REPORT

TABLE OF CONTENTS

Page

PART I.

FINANCIAL INFORMATION

Item 1.

Financial Statements (Unaudited)

Condensed Consolidated Balance Sheets as of February 28, 2023 and May 31, 2022

Condensed Consolidated Statements of Operations for the Three and Nine Months Ended February 28, 2023 and 2022

Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended February 28, 2023 and 2022

Condensed Consolidated Statements of Stockholders Deficit for the Three and Nine Months Ended February 28, 2023 and 2022

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended February 28, 2023 and 2022

Notes to Condensed Consolidated Financial Statements

Item 2.

Management s Discussion and Analysis of Financial Condition and Results of Operations

27

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

45

Item 4.

Controls and Procedures

46

PART II.

OTHER INFORMATION

47

Item 1.

Legal Proceedings

47

Item 1A.

Risk Factors

47

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

47

Item 6.

Exhibits

48

Signatures

49

Table of Contents

Cautionary Note on Forward-Looking Statements

For purposes of this Quarterly Report on Form 10-Q (this Quarterly Report), the terms Oracle, we, us and our refer to Oracle Corporation and its consolidated subsidiaries. This Quarterly Report contains statements that are not historical in nature, are predictive in nature, or that depend upon or refer to future events or conditions or otherwise contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act), and Section 27A of the Securities Act of 1933, as amended (Securities Act). These include, among other things, statements regarding:

our expectation that we may acquire, and realize the anticipated benefits of acquiring, companies, products, services and technologies to further our corporate strategy as compelling opportunities become available

our expectation that, on a constant currency basis, our total cloud and license revenues generally will continue to increase due to expected growth in our cloud services and license support offerings, and continued demand for our cloud license and on-premise license offerings

our expectation that substantially all of our customers will renew their license support contracts annually

our expectation that our hardware business will have lower operating margins as a percentage of revenues than our cloud and license business

our expectation that we will continue to make significant investments in research and development, and our belief that research and development efforts are essential to maintaining our competitive position

our expectation that our international operations will continue to provide a significant portion of our total revenues and expenses

our expectation that variable expenditures that were curtailed primarily in response to COVID-19 may normalize in future periods provided global economic and health conditions improve

our expectation that the proportion of our cloud services revenues relative to our total revenues will continue to increase

the sufficiency of our sources of funding for working capital, capital expenditures, contractual obligations, acquisitions, dividends, stock repurchases, debt repayments and other matters

our belief that we have adequately provided under U.S. generally accepted accounting principles for outcomes related to our tax audits and that the final outcome of our tax-related examinations, agreements or judicial proceedings will not have a material effect on our results of operations, and our belief that our net deferred tax assets will likely be realized in the foreseeable future

our belief that the outcome of certain legal proceedings and claims to which we are a party will not, individually or in the aggregate, result in losses that are materially in excess of amounts already recognized, if any

our expectation that certain litigation related charges and other expenses will not recur

the possibility that certain legal proceedings to which we are a party could have a material impact on our financial position or results of operations

the timing and amount of expenses we expect to incur

the cost savings we expect to realize pursuant to our Fiscal 2022 Oracle Restructuring Plan

declarations of future cash dividend payments and the timing and amount of future stock repurchases, including our expectation that the levels of our future stock repurchase activity may be modified in comparison to past periods in order to use available cash for other purposes

Table of Contents

our expectations regarding the impact of recent accounting pronouncements on our consolidated financial statements

our ability to predict revenues, particularly certain cloud license and on-premise license revenues and hardware revenues

the percentages of remaining performance obligations that we expect to recognize as revenues over respective future periods

as well as other statements regarding our future operations, financial condition and prospects, and business strategies. Forward-looking statements may be preceded by, followed by or include the words expects, anticipates, intends, plans, believes, seeks, strives, endeavors, estimates, will, should, is designed to and similar expressions. We claim the protection of the safe harbor for forward-looking statements contained in the Exchange Act and the Securities Act for all forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to risks, uncertainties and assumptions about our business that could affect our future results and could cause those results or other outcomes to differ materially from those expressed or implied in the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in Risk Factors included in documents we file from time to time with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for our fiscal year ended May 31, 2022 and our other Quarterly Reports on Form 10-Q filed by us in our fiscal 2023, which runs from June 1, 2022 to May 31, 2023.

We have no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or risks, except to the extent required by applicable securities laws. If we do update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. New information, future events or risks could cause the forward-looking events we discuss in this Quarterly Report not to occur. You should not place undue reliance on these forward-looking statements, which reflect our expectations only as of the date of this Quarterly Report.

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements (Unaudited)

ORACLE CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

As of February 28, 2023 and May 31, 2022

(Unaudited)

(in millions, except per share data)

February 28,

2023

May 31,

2022

ASSETS

Current assets:

Cash and cash equivalents

8,219

21,383

Marketable securities

550

519

Trade receivables, net of allowances for credit losses of $400 and $362 as of February 28, 2023 and May 31, 2022, respectively

6,213

5,953

Prepaid expenses and other current assets

3,714

3,778

Total current assets

18,696

31,633

Non-current assets:

Property, plant and equipment, net

16,345

9,716

Intangible assets, net

10,707

1,440

Goodwill, net

61,499

43,811

Deferred tax assets

12,153

12,782

Other non-current assets

12,220

9,915

Total non-current assets

112,924

77,664

Total assets

131,620

109,297

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current liabilities:

Notes payable and other borrowings, current

5,415

3,749

Accounts payable

1,610

1,317

Accrued compensation and related benefits

1,736

1,944

Deferred revenues

8,598

8,357

Other current liabilities

5,521

4,144

Total current liabilities

22,880

19,511

Non-current liabilities:

Notes payable and other borrowings, non-current

86,396

72,110

Income taxes payable

11,335

12,210

Deferred tax liabilities

6,814

6,031

Other non-current liabilities

6,107

5,203

Total non-current liabilities

110,652

95,554

Commitments and contingencies

Oracle Corporation stockholders' deficit:

Preferred stock, $0.01 par value authorized: 1.0 shares outstanding: none

Common stock, $0.01 par value and additional paid in capital authorized: 11,000 shares outstanding: 2,700 shares and 2,665 shares as of February 28, 2023 and May 31, 2022, respectively

28,994

26,808

Accumulated deficit

(29,721

(31,336

Accumulated other comprehensive loss

(1,694

(1,692

Total Oracle Corporation stockholders' deficit

(2,421

(6,220

Noncontrolling interests

509

452

Total stockholders' deficit

(1,912

(5,768

Total liabilities and stockholders' deficit

131,620

109,297

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the Three and Nine Months Ended February 28, 2023 and 2022

(Unaudited)

Three Months Ended

February 28,

Nine Months Ended

February 28,

(in millions, except per share data)

2023

2022

2023

2022

Revenues:

Cloud services and license support

8,923

7,637

25,938

22,562

Cloud license and on-premise license

1,288

1,289

3,627

3,339

Hardware

811

798

2,424

2,328

Services

1,376

789

4,129

2,371

Total revenues

12,398

10,513

36,118

30,600

Operating expenses:

Cloud services and license support(1)

1,980

1,305

5,606

3,778

Hardware(1)

244

244

780

718

Services(1)

1,215

669

3,448

1,984

Sales and marketing(1)

2,150

2,004

6,544

5,811

Research and development

2,146

1,816

6,397

5,254

General and administrative

402

335

1,179

953

Amortization of intangible assets

886

279

2,712

882

Acquisition related and other

37

20

140

4,707

Restructuring

78

19

359

89

Total operating expenses

9,138

6,691

27,165

24,176

Operating income

3,260

3,822

8,953

6,424

Interest expense

(908

(667

(2,550

(2,051

Non-operating expenses, net

(134

(315

(386

(348

Income before income taxes

2,218

2,840

6,017

4,025

Provision for income taxes

322

521

833

497

Net income

1,896

2,319

5,184

3,528

Earnings per share:

Basic

0.70

0.87

1.93

1.30

Diluted

0.68

0.84

1.88

1.26

Weighted average common shares outstanding:

Basic

2,698

2,670

2,692

2,711

Diluted

2,776

2,754

2,757

2,800

(1)

Exclusive of amortization of intangible assets, which is shown separately.

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the Three and Nine Months Ended February 28, 2023 and 2022

(Unaudited)

Three Months Ended

February 28,

Nine Months Ended

February 28,

(in millions)

2023

2022

2023

2022

Net income

1,896

2,319

5,184

3,528

Other comprehensive income (loss), net of tax:

Net foreign currency translation gains (losses)

11

(63

(183

(508

Net unrealized gains on cash flow hedges

71

181

Other, net

Total other comprehensive income (loss), net

83

(62

(2

(503

Comprehensive income

1,979

2,257

5,182

3,025

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS DEFICIT

For the Three and Nine Months Ended February 28, 2023 and 2022

(Unaudited)

Three Months Ended

February 28,

Nine Months Ended

February 28,

(in millions, except per share data)

2023

2022

2023

2022

Common stock and additional paid in capital

Balance, beginning of period

28,148

25,591

26,808

26,533

Common stock issued

98

52

759

357

Stock-based compensation

924

674

2,583

1,900

Repurchases of common stock

(18

(65

(153

(1,648

Other, net

(158

(123

(1,003

(1,013

Balance, end of period

28,994

26,129

28,994

26,129

Accumulated deficit

Balance, beginning of period

(30,617

(34,076

(31,336

(20,120

Repurchases of common stock

(137

(535

(983

(13,952

Cash dividends declared

(863

(855

(2,586

(2,603

Net income

1,896

2,319

5,184

3,528

Balance, end of period

(29,721

(33,147

(29,721

(33,147

Other stockholders' deficit, net

Balance, beginning of period

(1,307

(1,173

(1,240

(461

Other comprehensive income (loss), net

83

(62

(2

(503

Other, net

39

42

57

(229

Balance, end of period

(1,185

(1,193

(1,185

(1,193

Total stockholders' deficit

(1,912

(8,211

(1,912

(8,211

Cash dividends declared per common share

0.32

0.32

0.96

0.96

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Nine Months Ended February 28, 2023 and 2022

(Unaudited)

Nine Months Ended

February 28,

(in millions)

2023

2022

Cash flows from operating activities:

Net income

5,184

3,528

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation

1,810

1,409

Amortization of intangible assets

2,712

882

Deferred income taxes

(1,253

(983

Stock-based compensation

2,583

1,900

Other, net

487

82

Changes in operating assets and liabilities, net of effects from acquisitions:

Decrease in trade receivables, net

460

652

Decrease in prepaid expenses and other assets

515

71

Decrease in accounts payable and other liabilities

(783

(683

Decrease in income taxes payable

(453

(661

Increase (decrease) in deferred revenues

256

(643

Net cash provided by operating activities

11,518

5,554

Cash flows from investing activities:

Purchases of marketable securities and other investments

(921

(10,134

Proceeds from sales and maturities of marketable securities and other investments

552

25,735

Acquisitions, net of cash acquired

(27,721

(132

Capital expenditures

(6,782

(3,088

Net cash (used for) provided by investing activities

(34,872

12,381

Cash flows from financing activities:

Payments for repurchases of common stock

(1,150

(15,654

Proceeds from issuances of common stock

759

357

Shares repurchased for tax withholdings upon vesting of restricted stock-based awards

(1,040

(1,011

Payments of dividends to stockholders

(2,586

(2,603

Proceeds from issuances of commercial paper, net of repayments

1,874

Proceeds from issuances of senior notes and other borrowings, net of issuance costs

33,494

Repayments of senior notes and other borrowings

(21,050

(5,750

Other, net

49

(439

Net cash provided by (used for) financing activities

10,350

(25,100

Effect of exchange rate changes on cash and cash equivalents

(160

(251

Net decrease in cash and cash equivalents

(13,164

(7,416

Cash and cash equivalents at beginning of period

21,383

30,098

Cash and cash equivalents at end of period

8,219

22,682

Non-cash financing activities:

Fair values of stock awards assumed in connection with acquisitions

55

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

February 28, 2023

(Unaudited)

1.

BASIS OF PRESENTATION, RECENT ACCOUNTING PRONOUNCEMENTS AND OTHER

Basis of Presentation

We have prepared the condensed consolidated financial statements included herein pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. However, we believe that the disclosures herein are adequate to ensure the information presented is not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2022.

The comparability of our condensed consolidated financial statements as of and for the nine months ended February 28, 2023 was impacted by $4.7 billion of certain litigation related charges during the first nine months of fiscal 2022. Refer to Note 16 to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended May 31, 2022 for additional information.

On June 8, 2022, we completed our acquisition of Cerner Corporation (Cerner), a provider of digital information systems used within hospitals and health systems, by means of a merger of one of our wholly owned subsidiaries with and into Cerner such that Cerner became an indirect, wholly owned subsidiary of Oracle. Through our acquisition of Cerner, we enhanced our offerings of each of our three existing businesses, cloud and license, hardware and services. The condensed consolidated financial statements included in this Quarterly Report include the financial results of Cerner prospectively from the date of acquisition. Refer to Note 2 below for additional details regarding our acquisition of Cerner.

We believe that all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the operating results to be expected for any subsequent interim period or for our fiscal year ending May 31, 2023.

There have been no changes to our significant accounting policies as disclosed in our Annual Report on Form 10-K for the fiscal year ended May 31, 2022 that had a significant impact on our condensed consolidated financial statements or notes thereto as of and for the nine months ended February 28, 2023.

Use of Estimates

Our condensed consolidated financial statements are prepared in accordance with GAAP as set forth in the Financial Accounting Standards Board s (FASB) Accounting Standards Codification, and we consider various staff accounting bulletins and other applicable guidance issued by the SEC. These accounting principles require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent that there are differences between these estimates, judgments or assumptions and actual results, our consolidated financial statements will be affected. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management s judgment in its application. There are also areas in which management s judgment in selecting among available alternatives would not produce a materially different result.

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

February 28, 2023

(Unaudited)

During the first quarter of fiscal 2023, we completed an assessment of the useful lives of our servers and increased the estimate of the useful lives from four years to five years effective at the beginning of fiscal 2023. Based on the carrying value of our servers as of May 31, 2022, this change in accounting estimate decreased our total operating expenses by $101 million and $346 million for the third quarter and first nine months of fiscal 2023, respectively.

Cash, Cash Equivalents and Restricted Cash

Restricted cash that was included within cash and cash equivalents as presented within our condensed consolidated balance sheets as of February 28, 2023 and May 31, 2022 and our condensed consolidated statements of cash flows for the nine months ended February 28, 2023 and 2022 was nominal.

Remaining Performance Obligations from Contracts with Customers

Trade receivables, net of allowance for credit losses, and deferred revenues are reported net of related uncollected deferred revenues in our condensed consolidated balance sheets as of February 28, 2023 and May 31, 2022. The revenues recognized during the nine months ended February 28, 2023 and 2022, respectively, that were included in the opening deferred revenues balances as of May 31, 2022 and 2021, respectively, were approximately $7.7 billion and $8.1 billion, respectively. Revenues recognized from performance obligations satisfied in prior periods and impairment losses recognized on our receivables were immaterial in each of the three and nine months ended February 28, 2023 and 2022, respectively.

Remaining performance obligations, as defined in Note 1 of Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2022, were $62.3 billion as of February 28, 2023, approximately 48% of which we expect to recognize as revenues over the next twelve months, 35% over the subsequent month 13 to month 36, and the remainder thereafter.

Sales of Financing Receivables

We offer certain of our customers the option to acquire certain of our cloud and license, hardware and services offerings through separate long-term payment contracts. We generally sell these contracts that we have financed for our customers on a non-recourse basis to financial institutions within 90 days of the contracts dates of execution. We record the transfers of amounts due from customers to financial institutions as sales of financing receivables because we are considered to have surrendered control of these financing receivables. Financing receivables sold to financial institutions were $344 million and $1.5 billion for the three and nine months ended February 28, 2023, respectively, and $352 million and $1.4 billion for the three and nine months ended February 28, 2022, respectively.

Non-Marketable Investments

Our non-marketable debt investments and equity securities and related instruments totaled $2.1 billion and $1.2 billion as of February 28, 2023 and May 31, 2022, respectively, and are included in other non-current assets in the accompanying consolidated balance sheets and are subject to periodic impairment reviews. Certain of these non-marketable equity securities and related instruments are adjusted for observable price changes from orderly transactions. The majority of the non-marketable investments held as of these dates were with a related party entity for which we follow the equity method of accounting. We are also a counterparty to certain options to acquire additional equity interests in that entity at various times through June 2025 and we could obtain control of that entity should such options be exercised.

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

February 28, 2023

(Unaudited)

Acquisition Related and Other Expenses

Acquisition related and other expenses primarily consist of personnel related costs for transitional and certain other employees, certain business combination adjustments, including adjustments after the measurement period has ended, and certain other operating items, net. For the nine months ended February 28, 2022, acquisition related and other expenses included certain litigation related charges.

Three Months Ended

February 28,

Nine Months Ended

February 28,

(in millions)

2023

2022

2023

2022

Transitional and other employee related costs

15

52

Business combination adjustments, net

10

Other, net

20

13

78

4,693

Total acquisition related and other expenses

37

20

140

4,707

Non-Operating Expenses, net

Non-operating expenses, net consists primarily of interest income, net foreign currency exchange losses, the noncontrolling interests in the net profits of our majority-owned subsidiaries (primarily Oracle Financial Services Software Limited and Oracle Corporation Japan), net losses related to equity investments including losses attributable to equity method investments and net other income and expenses, including net unrealized gains and losses from our investment portfolio related to our deferred compensation plan, and non-service net periodic pension income and losses.

Three Months Ended

February 28,

Nine Months Ended

February 28,

(in millions)

2023

2022

2023

2022

Interest income

90

16

180

56

Foreign currency losses, net

(55

(29

(181

(109

Noncontrolling interests in income

(41

(42

(120

(131

Losses from equity investments, net

(122

(197

(249

(138

Other losses, net

(6

(63

(16

(26

Total non-operating expenses, net

(134

(315

(386

(348

Recent Accounting Pronouncements

Financial Instruments: In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04) and also issued subsequent amendments to the initial guidance (collectively, Topic 848). Topic 848 provides optional guidance for contract modifications and certain hedging relationships associated with the transition from reference rates that are expected to be discontinued. We will adopt Topic 848 when our relevant contracts are modified upon transition to alternative reference rates. We do not expect our adoption of Topic 848 to have a material impact on our consolidated financial statements.

10

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

February 28, 2023

(Unaudited)

2.

ACQUISITIONS

Acquisition of Cerner Corporation

On December 20, 2021, we entered into an Agreement and Plan of Merger (Merger Agreement) with Cerner, a provider of digital information systems used within hospitals and health systems that are designed to enable medical professionals to deliver better healthcare to individual patients and communities.

On January 19, 2022, pursuant to the Merger Agreement, we commenced a tender offer to purchase all of the issued and outstanding shares of common stock of Cerner at a purchase price of $95.00 per share, net to the seller in cash, without interest thereon, based upon the terms and subject to the conditions set forth in the Offer to Purchase dated January 19, 2022, and the related Letter of Transmittal.

On June 8, 2022, pursuant to the terms of the tender offer and applicable Delaware law, we acquired all the outstanding Cerner shares and effectuated the merger of Cerner with and into a wholly-owned subsidiary of Oracle and Cerner became an indirect, wholly-owned subsidiary of Oracle. Vested equity awards outstanding immediately prior to the consummation of the merger were cancelled in exchange for the right to receive an amount in cash based on a formula contained in the Merger Agreement. The unvested equity awards to acquire Cerner common stock that were outstanding immediately prior to the conclusion of the merger were converted into equity awards denominated in shares of Oracle common stock based on formulas contained in the Merger Agreement. We have included the financial results of Cerner in our consolidated financial statements from the date of acquisition. For the third quarter and first nine months of fiscal 2023, Cerner contributed $1.5 billion and $4.4 billion to our total revenues, respectively.

The total purchase price for Cerner was $28.2 billion, which consisted of $28.2 billion in cash and $55 million for the fair values of restricted stock-based awards and stock options assumed. Pursuant to our business combinations accounting policy, we estimated the preliminary fair values of net tangible and intangible assets acquired, and the excess of the consideration transferred over the aggregate of such fair values was recorded as goodwill. The preliminary fair values of net tangible assets and intangible assets acquired were based on preliminary valuations, and our estimates and assumptions are subject to change within the measurement period (up to one year from the acquisition date). The primary areas that remain preliminary relate to the fair values of intangible assets acquired, certain tangible assets and liabilities acquired, certain legal matters, income and non-income based taxes and residual goodwill. We expect to continue to obtain information to assist us in determining the fair values of the net assets acquired during the measurement period. The following table summarizes the estimated preliminary fair values of net tangible and intangible assets acquired from Cerner:

(in millions)

Cash and marketable securities

769

Trade receivables, net

793

Property, plant and equipment, net

1,512

Intangible assets

11,972

Goodwill

17,837

Other assets

839

Accounts payable and other liabilities

(993

Deferred revenues

(297

Senior notes and other borrowings

(1,600

Deferred tax liabilities, net

(2,607

Total

28,225

11

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

February 28, 2023

(Unaudited)

All of the $1.6 billion of senior notes and other borrowings assumed through our Cerner acquisition were paid during the first half of fiscal 2023. Refer to Note 5 below for more information. We do not expect the goodwill recognized as a part of our acquisition of Cerner to be deductible for income tax purposes.

Other Fiscal 2023 and 2022 Acquisitions

During the first nine months of fiscal 2023 and full year fiscal 2022, we acquired certain other companies and purchased certain technology and development assets primarily to expand our products and services offerings. These acquisitions were not significant individually or in the aggregate to our condensed consolidated financial statements.

Unaudited Pro Forma Financial Information

The unaudited pro forma financial information in the table below summarizes the combined results of operations for Oracle and Cerner. The unaudited pro forma financial information for all periods presented included the business combination accounting effects resulting from this acquisition, including amortization charges from acquired intangible assets (certain of which are preliminary), stock-based compensation charges for unvested restricted stock-based awards and stock options assumed and the related tax effects as though Cerner was combined as of the beginning of fiscal 2022. The unaudited pro forma financial information as presented below is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of fiscal 2022.

The unaudited pro forma financial information for the three and nine months ended February 28, 2023 and 2022 combined the historical results of Oracle for the three and nine months ended February 28, 2023 and 2022, respectively, the historical results of Cerner for the three and nine months ended December 31, 2022 and 2021, respectively (adjusted due to differences in reporting periods and considering the date we acquired Cerner), and the effects of the pro forma adjustments listed above. The unaudited pro forma financial information was as follows:

Three Months Ended

February 28,

Nine Months Ended

February 28,

(in millions, except per share data)

2023

2022

2023

2022

Total revenues

12,398

11,956

36,228

34,954

Net income

1,896

1,938

5,137

2,143

Basic earnings per share

0.70

0.73

1.91

0.79

Diluted earnings per share

0.68

0.70